CBT Delivery Was Embedded Into Tuberculosis Care in Khyber Pakhtunkhwa
Embedding cognitive behavioural therapy into routine tuberculosis care is a pragmatic response to a problem that rarely stays confined to one organ system. Depression can blunt adherence, sap motivation, and make a long anti-tuberculosis regimen even harder to complete. In Khyber Pakhtunkhwa, Pakistan, a pilot randomised trial process evaluation examined how a CBT-based intervention could be delivered alongside treatment for patients with tuberculosis, using a mixed-methods design that drew on both quantitative and qualitative data.
The evaluation brought together perspectives from therapists, medical officers, trial staff, and patients. That mattered because implementation questions in real clinics are rarely captured by a single data stream. Fidelity, acceptability, and day-to-day feasibility all sit at the bedside, not just in the protocol file.
Fidelity Was Measured Against a Pre-Specified Competency Threshold
Delivery quality was assessed with the Revised Cognitive Therapy Scale, a validated measure of CBT competence. A pre-specified competency threshold provided an objective benchmark for judging whether the intervention was being delivered with enough consistency to make the pilot meaningful. Direct structured observation formed the basis of fidelity assessment, rather than audio recordings, which kept the evaluation close to the way the therapy was actually supervised in practice.
That design choice is clinically important. CBT is not simply a matter of repeating a script; it depends on timing, therapeutic structure, collaborative problem-solving, and the ability to help a patient identify and reframe thoughts that can deepen hopelessness or resistance to care. In a tuberculosis clinic, where appointment load, stigma, travel burden, and competing medical needs can all interrupt attendance, fidelity is inseparable from feasibility.
The process evaluation was built around a pilot randomised controlled trial, so its role was implementation-focused rather than efficacy-focused. It tested whether the intervention could be delivered, received, and judged credible within the constraints of routine care. It did not set out to answer whether the therapy was cost-effective, leaving the economic case for scale-up unmeasured in this phase.
Patients Who Stayed Engaged Shaped the Qualitative Picture
The qualitative interviews were restricted to patients who attended at least four CBT sessions. Participants who stopped earlier were not interviewed, a selection pattern that likely favored those with better engagement or more favorable experiences. In implementation research, that kind of filter can make the intervention look smoother than it may have felt for people who struggled to stay involved.
Still, the choice reveals something practical about the minimum exposure needed to judge a psychological intervention inside infectious disease care. Four sessions is not a trivial commitment for someone managing tuberculosis treatment, particularly in settings where transport costs, work disruption, and stigma can erode follow-up. Attendance at that level suggests a degree of patient persistence and service reach that is itself meaningful in a busy provincial health system.
A psychotherapy intervention in this setting has to clear several barriers at once. It must be understandable to patients with depression, workable for therapists who are not embedded in mental health specialty settings, and compatible with the time demands of tuberculosis care. The process evaluation was designed to see whether those layers held together in practice.
Why Depression Treatment Matters in Tuberculosis Care
The logic for integrating CBT into tuberculosis treatment is straightforward at the clinical level. Depression can impair concentration, reduce self-efficacy, weaken medication routines, and intensify the sense that treatment is endless or futile. In a disease that already demands prolonged adherence, symptom monitoring, and repeated contact with the health system, untreated psychological distress can become a direct obstacle to cure.
CBT is well suited to this problem because it targets the thoughts and behaviors that sustain avoidance and disengagement. When applied inside tuberculosis care, it may help patients reorganize catastrophic thinking, improve coping, and restore enough agency to continue treatment. The intervention therefore sits at the intersection of mental health and infectious disease management, where adherence is often the clinical hinge.
The process evaluation did not try to prove that mechanism through outcome superiority. Instead, it asked a narrower but necessary question: can the therapy be delivered with acceptable competency, and do the people involved see it as workable? For implementation science, that is often the difference between a concept that sounds appealing and a model that can survive routine service pressures.
Triangulation Strengthened the Implementation Readout
Methodological triangulation gave the evaluation its strength. By combining patient interviews with staff perspectives and structured competency assessment, the study could compare what was intended, what was delivered, and what patients experienced. Convergent findings across those perspectives would support confidence in the intervention’s internal coherence. Divergence would have pointed to specific failure points in supervision, delivery, or acceptability.
The inclusion of therapists, medical officers, and trial staff also reflects the real chain of delivery in integrated care. Psychological treatment in a tuberculosis program does not happen in isolation; it depends on staff who can identify eligible patients, maintain referral flow, and protect time for sessions without disrupting core infectious disease work. The pilot design therefore assessed not only the therapy itself but also the service architecture around it.
One sentence captures the central implementation challenge: a therapy can be evidence-based and still fail if the clinic cannot carry it.
The Pilot Leaves Scale-Up Questions Unanswered
Several limits frame how far these findings can travel. The qualitative sample excluded patients who dropped out before four sessions, so the experience of early discontinuation remains unclear. Cost-effectiveness was not evaluated, leaving unanswered questions about staffing, supervision, and affordability if the intervention were expanded beyond a pilot setting. The fidelity assessment relied on structured observation rather than audio review, which may influence how supervision translates into broader roll-out settings.
Even with those constraints, the evaluation offers a useful operational lesson for tuberculosis programs considering mental health integration. Competence can be assessed, feasibility can be mapped, and patient acceptance can be explored before a larger effectiveness trial is launched. What still needs to be established is whether this model can retain fidelity and reach the patients most likely to disengage, not only those willing to complete several sessions.
For now, the study places CBT inside a tuberculosis clinic rather than outside it, where depression and adherence problems often remain invisible to routine care. The next step is not simply more enthusiasm for integration. It is a larger trial that can test whether the intervention reaches the people who need it most, whether it can be sustained by the health system, and whether the added psychiatric care changes the course of tuberculosis treatment in measurable ways.